Total planned funding: $412,371,375
Clear active filters
Zimbabwe
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Zimbabwe | $412,371,375 |
Organizational Types
Private Contractor | $129,096,489 |
NGO | $108,415,473 |
Unknown | $80,048,001 |
Own Agency | $47,672,453 |
Implementing Agency | $22,473,433 |
University | $9,833,385 |
Other USG Agency | $7,043,000 |
FBO | $6,039,141 |
Host Country Government Agency | $1,700,000 |
Multi-lateral Agency | $50,000 |
Program Areas
Treatment | $142,874,964 |
Prevention | $103,430,753 |
Care | $68,373,825 |
Governance and Systems | $35,978,827 |
Testing | $33,339,178 |
Management and Operations | $28,373,828 |
Budget Codes
HTXD: Treatment: ARV Drugs | $75,919,016 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $65,262,083 |
HTXS: Treatment: Adult Treatment | $61,464,231 |
HKID: Care: Orphans and Vulnerable Children | $35,851,400 |
HVCT: Testing: HIV Testing and Counseling | $33,339,178 |
HVMS: Management and Operations | $28,373,828 |
OHSS: Health Systems Strengthening | $19,700,650 |
HBHC: Care: Adult Care and Support | $18,549,032 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $13,996,795 |
HVOP: Sexual Prevention: Other Sexual Prevention | $13,145,933 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $10,100,942 |
HVTB: Care: TB/HIV | $9,448,096 |
HVSI: Strategic Information | $8,920,036 |
HLAB: Laboratory Infrastructure | $7,358,141 |
PDTX: Treatment: Pediatric Treatment | $5,491,717 |
PDCS: Care: Pediatric Care and Support | $4,525,297 |
HMBL: Biomedical Prevention: Blood Safety | $825,000 |
HMIN: Biomedical Prevention: Injection Safety | $100,000 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Not Available:
$80,628,001
Countries/Regions
USG Aggregated Agencies:
$35,836,103
Countries/Regions
University of Washington:
$29,791,857
Countries/Regions